Bacil Pharma informs about quarterly statement on investor complaint

15 Jan 2016

Bacil Pharma has informed about quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Related Bacil Pharma Ltd. Links:

Bacil Pharma Share Price

2.80 0.00 (0.00%) Jul 06, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 493.45
Dr. Reddys Lab 3905.80
Lupin 860.75
Piramal Enterprises 1449.20
Cadila Healthcare 356.25
View more..
Sensex vs Bacil Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback